CAH241227C117000
- 1.39
- -0.20-12.58%
Cardinal Health Newsroom
Cardinal Health Is Maintained at Overweight by Morgan Stanley
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $136
Cardinal Health Raised to Equal-Weight From Underweight by Wells Fargo
Cardinal Health Analyst Ratings
Wells Fargo Upgrades Cardinal Health(CAH.US) to Hold Rating, Raises Target Price to $127
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $149
Baird Adjusts Cardinal Health Price Target to $149 From $145, Maintains Outperform Rating
Jefferies Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $125
J.P. Morgan Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $132
J.P. Morgan Remains a Hold on Cardinal Health (CAH)
JPMorgan Adjusts Price Target on Cardinal Health to $132 From $123, Maintains Neutral Rating
Wells Fargo Maintains Cardinal Health(CAH.US) With Sell Rating, Maintains Target Price $101
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $101 to $138
Cardinal Health's Strategic Acquisitions and Financial Strength Drive Buy Rating
Evercore ISI Remains a Hold on Cardinal Health (CAH)
A Quick Look at Today's Ratings for Cardinal Health(CAH.US), With a Forecast Between $124 to $139
Cardinal Health Is Maintained at Overweight by Barclays
Cardinal Health's Strong Pharmaceutical Growth and Strategic Moves Justify Buy Rating
Barclays Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $133
TD Cowen Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $130